Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

Obesity is a major public health challenge in the United States, with more than 40% of Americans affected. This chronic ...

Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to ...

Margaret Stamp returned home to Sarpy County from college four weeks after her 74-year-old grandmother, Phyllis Behm, had ...

Recent medical research reveals striking differences between surgical and pharmaceutical approaches to weight ... Insurance ...

According to Columbia University’s Center for Metabolic and Weight Loss Surgery, deciding to take drugs like Ozempic requires ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is linked to a “high burden” of symptoms and physical limitations that affect a ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

This article unravels the coverage of weight loss surgery under health insurance policies in India, offering crucial guidance for those contemplating this transformative procedure. Most insurance ...